TWiV 961: Clinical update with Dr. Daniel Griffin
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In his weekly clinical update Dr. Griffin discusses Mpox (formerly monkeypox) in women: epidemiological features and clinical characteristics of mpox cases in Spain, April to November 2022, triage of patients with Ebola virus disease, SARS-CoV-2 serology and self-reported infection among adults, serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals, sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants, effect of wearing glasses on risk of infection with SARS-CoV-2 in the community, and data-driven identification of post-acute SARS-CoV-2 infection subphenotypes.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Mpox in women: Epidemiological features and clinical characteristics of cases (Eurosurveillance)
- Triage of patients with Ebola virus disease (The Lancet)
- SARS-CoV-2 serology and self-reported infection among adults (CDC)
- Serological markers of SARS-CoV-2 infection (JID)
- Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody (Journal of infection)
- Effect of wearing glasses on risk of infection with SARS-CoV-2 in the community (JAMA)
- Paxlovid patient eligbiliity screening checklist (FDA)
- Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes (Nature)
- Contribute to our MicrobeTV fundraiser at PWB
- Dr. Griffin's treatment guide (pdf)
- Letters read on TWiV 961
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]